Redpoint Investment Management Pty LTD Eli Lilly & CO Transaction History

Redpoint Investment Management Pty LTD

$684 Million
Q3 2022

A detailed history of Redpoint Investment Management Pty LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 17,414 shares of LLY stock, worth $15.4 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

17,414

Previous 20,152 13.59%

Holding current value

$15.4 Million

Previous $6.53 Million 13.82%

% of portfolio

0.82%

Previous 0.77%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$296.48 - $337.87 $811,762 - $925,088	-2,738 Reduced 13.59%	17,414 $5.63 Million
Q2 2022 Jul 08, 2022	BUY	$278.73 - $327.27 $15,330 - $17,999	55 Added 0.27%	20,152 $6.53 Million
Q4 2021 Jan 19, 2022	SELL	$224.85 - $279.04 $88,815 - $110,220	-395 Reduced 1.93%	20,097 $5.55 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $388,464 - $478,060	-1,753 Reduced 7.88%	20,492 $4.74 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $157,981 - $204,347	-875 Reduced 3.78%	22,245 $5.11 Million
Q1 2021 Apr 13, 2021	BUY	$164.32 - $212.72 $23,333 - $30,206	142 Added 0.62%	23,120 $4.32 Million
Q4 2020 Jan 13, 2021	BUY	$130.46 - $172.63 $219,955 - $291,054	1,686 Added 7.92%	22,978 $3.88 Million
Q3 2020 Oct 09, 2020	SELL	$146.22 - $169.13 $4.25 Million - $4.92 Million	-29,098 Reduced 57.75%	21,292 $3.15 Million
Q2 2020 Jul 17, 2020	SELL	$136.42 - $164.18 $1.81 Million - $2.18 Million	-13,266 Reduced 20.84%	50,390 $8.27 Million
Q4 2019 Feb 25, 2020	SELL	$106.92 - $132.43 $479,856 - $594,345	-4,488 Reduced 6.59%	63,656 $8.37 Million
Q3 2019 Nov 26, 2019	BUY	$106.79 - $116.16 $88,101 - $95,832	825 Added 1.23%	68,144 $7.62 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $89,296 - $104,231	806 Added 1.21%	67,319 $7.46 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $8,125 - $9,564	73 Added 0.11%	66,513 $8.63 Million
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $91,497 - $102,504	-864 Reduced 1.28%	66,440 $7.69 Million
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $70,703 - $81,145	934 Added 1.41%	67,304 $5.74 Million
Q1 2018 Aug 09, 2018	BUY	$74.21 - $87.6 $425,668 - $502,473	5,736 Added 9.46%	66,370 $5.14 Million
Q4 2017 Aug 09, 2018	BUY	$81.94 - $87.89 $4.97 Million - $5.33 Million	60,634	60,634 $5.12 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.

Account

Redpoint Investment Management Pty LTD Eli Lilly & CO Transaction History